SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-16-136569
Filing Date
2016-08-03
Accepted
2016-08-03 16:31:29
Documents
48
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a16-11549_110q.htm 10-Q 500170
2 EX-3.1 a16-11549_1ex3d1.htm EX-3.1 12697
3 EX-31.1 a16-11549_1ex31d1.htm EX-31.1 17236
4 EX-31.2 a16-11549_1ex31d2.htm EX-31.2 17271
5 EX-32.1 a16-11549_1ex32d1.htm EX-32.1 8657
6 EX-32.2 a16-11549_1ex32d2.htm EX-32.2 8688
  Complete submission text file 0001104659-16-136569.txt   2314929

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT dprx-20160630.xml EX-101.INS 350148
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT dprx-20160630.xsd EX-101.SCH 23083
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT dprx-20160630_cal.xml EX-101.CAL 24896
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT dprx-20160630_def.xml EX-101.DEF 67114
11 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT dprx-20160630_lab.xml EX-101.LAB 232351
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT dprx-20160630_pre.xml EX-101.PRE 157847
Mailing Address 14 WALL ST. SUITE 3D NEW YORK NY 10005
Business Address 14 WALL ST. SUITE 3D NEW YORK NY 10005 212-269-2834
Dipexium Pharmaceuticals, Inc. (Filer) CIK: 0001497504 (see all company filings)

IRS No.: 271707962 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36351 | Film No.: 161804305
SIC: 2834 Pharmaceutical Preparations